Product Information
RIVASTIGMINE 4.6 MG/24HR PATCH is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $1.8155 per EA under NDC 51991089730. Its NADAC has been published 341 times since Feb 12, 2020.
FDA first approved this application on Nov 26, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4.6 mg/24h
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991089730
Classification
Generic
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Effective Date
8/19/2026
Active Ingredients
RIVASTIGMINEApproval Type
Generic (ANDA)
FDA Application
ANDA209063FDA Approved
11/26/2019
TE Code
AB
On Market Since
12/19/2019
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 4.6 MG/24HR PATCH has been published 341 times since Feb 12, 2020, and over the history we have for it it has declined 53.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8155 per EA |
|---|---|
| All-time high | $4.2113 (Sep 16, 2020) |
| All-time low | $1.4682 (Nov 20, 2024) |
| 52-week high | $1.8816 |
| 52-week low | $1.7654 |
| Median price | $2.0726 |
| Average price | $2.4402 |
| Largest weekly change | +42.4% (May 19, 2021) |
| Weeks tracked | 341 |
| Tracking since | Feb 12, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 4.6 MG/24HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.6 MG/24HR PATCH, manufactured by Breckenridge Pharmaceutical Inc., is $1.8155 per EA (NDC 51991089730), effective Aug 19, 2026.
How has the price of RIVASTIGMINE 4.6 MG/24HR PATCH changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 4.6 MG/24HR PATCH has declined 53.1%. It has been tracked across 341 weekly CMS publications since Feb 12, 2020.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.6 MG/24HR PATCH?
Since Feb 12, 2020, the NADAC for RIVASTIGMINE 4.6 MG/24HR PATCH has ranged from a low of $1.4682 (Nov 20, 2024) to a high of $4.2113 (Sep 16, 2020), with a median of $2.0726 per EA.
Are there cheaper alternatives to RIVASTIGMINE 4.6 MG/24HR PATCH?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVASTIGMINE 4.6 MG/24HR PATCH in a comparable dosage form, but none are currently priced below it.
Who manufactures RIVASTIGMINE 4.6 MG/24HR PATCH?
RIVASTIGMINE 4.6 MG/24HR PATCH (NDC 51991089730) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.